ForMED Ventures is a leading life science venture investment firm. Founded in 2016 by established entrepreneur Jane Liu, ForMED is dedicated to early-stage investments ranging between Seed to Expansion Capital. Our investments are mainly focused in Israel, Europe and the United States.
We are based in Taiwan, the heart of the Asia-Pacific region. Taiwan's capital market is home to many medtech and life science friendly investors, both in the private and public sectors. The island is also well-known for its success in precision machinery and the information and communications technology industry. ForMED leverages Taiwan’s industrial specialties for our portfolio companies.
Healthcare is undergoing a transformation more than ever due to the increased use of digital technology.
This has often blurred the boundaries amongst devices, medicines, and diagnostics in how they may serve patients today. We utilize a hologistic investment strategy to identify true opportunities in healthcare and bring value to our investors.
-
醫療器材 Medical Devices
-
數位醫療 Digital Health
-
生物科技 Biotechnology
良善循環 Core Value
ForMED is more than a fund. Our bounded duty is to reward investors’ trust in us with financial returns, while simultaneously allocating capital to areas of needs which may revolutionize the way we practice medicine today. What drives our brand of impact investing, is a simple idea -- that you can do well by doing good. It has created exciting business opportunities, and inspired investors to rethink where they put their money, and to invest responsibly.
As an institutional investor, we live by these virtues through investing in early-stage healthcare technologies and helping good ideas sprout so that they have the chance to be realized in commercial practices, bringing hopes to patients and their families. This is imperative as health often is a cornerstone to achieving personal goals and realizing individuals’ values in life.